SAFETY AND IMMUNOGENICITY OF SALMONELLA-TYPHI TY21A LIQUID FORMULATION VACCINE IN 4-YEAR-OLD TO 6-YEAR-OLD THAI CHILDREN

被引:23
作者
OLANRATMANEE, T
LEVINE, M
LOSONSKY, G
THISYAKORN, U
CRYZ, SJ
机构
[1] SWISS SERUM & VACCINE INST, POB 2707, CH-3001 BERN, SWITZERLAND
[2] CHULALONGKORN UNIV, BANGKOK 5, THAILAND
[3] CTR VACCINE DEV, BALTIMORE, MD USA
[4] CHACHOENGSAO HOSP, CHACHOENGSAO, THAILAND
关键词
D O I
10.1093/infdis/166.2.451
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:451 / 452
页数:2
相关论文
共 9 条
[1]  
BLACK R, 1982, DEV BIOLOGICALS, V53, P9
[2]   SAFETY, INFECTIVITY, IMMUNOGENICITY, AND INVIVO STABILITY OF 2 ATTENUATED AUXOTROPHIC MUTANT STRAINS OF SALMONELLA-TYPHI, 541TY AND 543TY, AS LIVE ORAL VACCINES IN HUMANS [J].
LEVINE, MM ;
HERRINGTON, D ;
MURPHY, JR ;
MORRIS, JG ;
LOSONSKY, G ;
TALL, B ;
LINDBERG, AA ;
SVENSON, S ;
BAQAR, S ;
EDWARDS, MF ;
STOCKER, B .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (03) :888-902
[3]  
LEVINE MM, 1990, LANCET, V336, P891
[4]  
LEVINE MM, 1989, REV INFECT DIS, V11, pS552
[5]   IMMUNOGENICITY OF SALMONELLA-TYPHI TY21A VACCINE FOR YOUNG-CHILDREN [J].
MURPHY, JR ;
GREZ, L ;
SCHLESINGER, L ;
FERRECCIO, C ;
BAQAR, S ;
MUNOZ, C ;
WASSERMAN, SS ;
LOSONSKY, G ;
OLSON, JG ;
LEVINE, MM .
INFECTION AND IMMUNITY, 1991, 59 (11) :4291-4293
[6]   CHARACTERISTICS OF HUMORAL AND CELLULAR-IMMUNITY TO SALMONELLA-TYPHI IN RESIDENTS OF TYPHOID-ENDEMIC AND TYPHOID-FREE REGIONS [J].
MURPHY, JR ;
BAQAR, S ;
MUNOZ, C ;
SCHLESINGER, L ;
FERRECCIO, C ;
LINDBERG, AA ;
SVENSON, S ;
LOSONSKY, G ;
KOSTER, F ;
LEVINE, MM .
JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (06) :1005-1009
[7]   ORAL IMMUNIZATION AGAINST TYPHOID-FEVER IN INDONESIA WITH TY21A VACCINE [J].
SIMANJUNTAK, CH ;
PALEOLOGO, FP ;
PUNJABI, NH ;
DARMOWIGOTO, R ;
TOTOSUDIRJO, SH ;
HARYANTO, P ;
SUPRIJANTO, E ;
WITHAM, ND ;
HOFFMAN, SL .
LANCET, 1991, 338 (8774) :1055-1059
[8]   TYPHOID AND PARATYPHOID FEVER IN 192 HOSPITALIZED CHILDREN IN THAILAND [J].
THISYAKORN, U ;
MANSUWAN, P ;
TAYLOR, DN .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1987, 141 (08) :862-865
[9]  
1986, NEW VACCINE DEV ESTA, V2, P1